This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

News

PCI Welcomes New Chief Financial Officer and SVP, Serge Dupuis

PCI is pleased to welcome Serge Dupuis as Senior Vice President and Chief Financial Officer.

Serge’s appointment supports PCI’s continued strategic growth and expansion across global network, currently spanning 20 facilities in eight locations across three continents. PCI features a broad portfolio of outsourced development and commercialization services focused in drug development and manufacturing, clinical trial supply, as well as commercial contract packaging.

Serge brings with him, more than 20 years’ experience in senior leadership roles, mainly in manufacturing environments. He joins the organization from CSP Technologies where he held the role of CFO. Prior to this, Serge served in significant senior-level roles with a range of internationally-recognized manufacturing and services, logistics and defense companies.

In welcoming Serge to PCI, Chief Executive Officer Salim Haffar said: “We are delighted Serge is joining us during this transformative time in PCI’s growth. His appointment is significant; confirming our long-standing commitment to partnering with leading pharmaceutical and biotech companies and help bring their life-saving medicines to patients around the world. Our trusted relationships with our customers are at the heart of all we do; our strategic growth plan, backed by robust global investment, reflects this. Serge will play an invaluable role as we build new capabilities and capacity, supported by innovative technology and first-class equipment – ensuring PCI continues to deliver outstanding quality and service for our clients in both established and emerging global markets.

Serge added: “I am excited to join the PCI organization, a very successful and unique leader in the pharmaceutical and biotech industry. I believe that PCI is very well-positioned and has a tremendous growth potential based on the impressive reputation, depth of knowledge and sizeable investment.

We have recently expanded operations through acquisition, adding key locations in San Diego, Dublin and Melbourne, as well as announcing a record year for capital investment across its global business.

March 22, 2019


$12M Investment to Expand Tredegar Manufacturing Capabilities

Doubles Capacity at Leading Edge Facility to Support Business Growth PCI Pharma Services is today pleased to announce that we... View Article

PCI Pharma Services Completes Expansion of its Specialty Drug Product Capabilities at Rockford, IL Site

Increases Capacity at State-of-the-Art Facility in Response to Growing Market Needs PHILADELPHIA–(BUSINESS WIRE)–PCI Pharma Services (PCI), a leading pharmaceutical and... View Article

x